Literature DB >> 25854552

An investigation of herpes simplex virus type 1 latency in a novel mouse dorsal root ganglion model suggests a role for ICP34.5 in reactivation.

R K Mattila1,2, K Harila1, S M Kangas3, H Paavilainen2,4, A M Heape3, I J Mohr5, V Hukkanen2.   

Abstract

After a primary lytic infection at the epithelia, herpes simplex virus type 1 (HSV-1) enters the innervating sensory neurons and translocates to the nucleus, where it establishes a quiescent latent infection. Periodically, the virus can reactivate and the progeny viruses spread back to the epithelium. Here, we introduce an embryonic mouse dorsal root ganglion (DRG) culture system, which can be used to study the mechanisms that control the establishment, maintenance and reactivation from latency. Use of acyclovir is not necessary in our model. We examined different phases of the HSV-1 life cycle in DRG neurons, and showed that WT HSV-1 could establish both lytic and latent form of infection in the cells. After reactivating stimulus, the WT viruses showed all markers of true reactivation. In addition, we showed that deletion of the γ(1)34.5 gene rendered the virus incapable of reactivation, even though the virus was clearly able to replicate and persist in a quiescent form in the DRG neurons.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854552     DOI: 10.1099/vir.0.000138

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  The γ134.5 Neurovirulence Gene of Herpes Simplex Virus 1 Modifies the Exosome Secretion Profile in Epithelial Cells.

Authors:  Outi Heikkilä; Elina Ryödi; Veijo Hukkanen
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Differentiated Human SH-SY5Y Cells Provide a Reductionist Model of Herpes Simplex Virus 1 Neurotropism.

Authors:  Mackenzie M Shipley; Colleen A Mangold; Chad V Kuny; Moriah L Szpara
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1.

Authors:  Kiira Kalke; Julius Orpana; Tuomas Lasanen; Olaya Esparta; Liisa M Lund; Fanny Frejborg; Tytti Vuorinen; Henrik Paavilainen; Veijo Hukkanen
Journal:  Viruses       Date:  2022-06-13       Impact factor: 5.818

4.  Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells.

Authors:  Kiira Kalke; Liisa M Lund; Marie C Nyman; Alesia A Levanova; Arto Urtti; Minna M Poranen; Veijo Hukkanen; Henrik Paavilainen
Journal:  PLoS Pathog       Date:  2022-07-06       Impact factor: 7.464

5.  Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23.

Authors:  Xing Liu; Dhiraj Acharya; Eric Krawczyk; Chase Kangas; Michaela U Gack; Bin He
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 12.779

Review 6.  Strength in diversity: Understanding the pathways to herpes simplex virus reactivation.

Authors:  Jon B Suzich; Anna R Cliffe
Journal:  Virology       Date:  2018-07-14       Impact factor: 3.616

Review 7.  The Role of Viral Proteins in the Regulation of Exosomes Biogenesis.

Authors:  Xiaonan Jia; Yiqian Yin; Yiwen Chen; Lingxiang Mao
Journal:  Front Cell Infect Microbiol       Date:  2021-05-13       Impact factor: 5.293

8.  Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors.

Authors:  Victor Cervera-Carrascon; Dafne C A Quixabeira; Riikka Havunen; Joao M Santos; Emma Kutvonen; James H A Clubb; Mikko Siurala; Camilla Heiniö; Sadia Zafar; Teija Koivula; Dave Lumen; Marjo Vaha; Arturo Garcia-Horsman; Anu J Airaksinen; Suvi Sorsa; Marjukka Anttila; Veijo Hukkanen; Anna Kanerva; Akseli Hemminki
Journal:  Mol Ther Oncolytics       Date:  2020-03-19       Impact factor: 7.200

Review 9.  Disturbed Yin-Yang balance: stress increases the susceptibility to primary and recurrent infections of herpes simplex virus type 1.

Authors:  Chang Yan; Zhuo Luo; Wen Li; Xue Li; Robert Dallmann; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2019-06-22       Impact factor: 11.413

10.  Enzymatically synthesized 2'-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity.

Authors:  Alesia A Levanova; Kiira M Kalke; Liisa M Lund; Nina Sipari; Mohammadreza Sadeghi; Marie C Nyman; Henrik Paavilainen; Veijo Hukkanen; Minna M Poranen
Journal:  Antiviral Res       Date:  2020-08-13       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.